Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 7.08
-0.11 (-1.53%)
Sep 10, 2026, 3:00 PM CST
SHA:603811 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 827.47 | 812.35 | 714.37 | 671.63 | 654.97 | 693.96 |
Revenue Growth | 6.74% | 13.72% | 6.36% | 2.54% | -5.62% | -8.46% |
Gross Profit Gross Profit Growth | 580.71 | 558.09 | 489.2 | 423.17 | 437.17 | 484.99 |
Operating Income Operating Income Growth | 165.44 | 173.02 | 123.43 | 120.71 | 115.34 | 153.78 |
Net Income Net Income Growth | 177.56 | 195.12 | 200.7 | 162.9 | 161.58 | 170.8 |
Earnings Per Share EPS Growth | 0.40 | 0.44 | 0.44 | 0.36 | 0.35 | 0.37 |
EPS Growth | -24.31% | 0% | 22.01% | 2.03% | -6.02% | 2.82% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Preparations Preparations Growth | 687.69 |
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth | 115.47 |
Intermediates and Others Intermediates and Others Growth | 2.7 |
Food Food Growth | 3.25 |
Traditional Chinese Medicine Traditional Chinese Medicine Growth | 1.76 |
Total Total Growth | 810.87 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 166.37 | 220.7 | 173.04 | 294.14 | 213.51 | 83.32 |
Total Debt Total Debt Growth | 49.91 | 37.75 | 230.86 | 443.84 | 426.8 | 148.54 |
Net Cash (Debt) Net Cash Growth | 116.46 | 182.95 | -57.82 | -149.7 | -213.3 | -65.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.26 | 0.41 | -0.13 | -0.33 | -0.46 | -0.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 279.99 | 280.39 | 205.72 | 194.78 | 165.94 | 143.49 |
Capital Expenditures CapEx Growth | -69.04 | -45.4 | -59.89 | -70.85 | -252.85 | -134.11 |
Free Cash Flow Free Cash Flow Growth | 210.96 | 234.99 | 145.83 | 123.93 | -86.92 | 9.38 |
Free Cash Flow Growth | -18.68% | 61.14% | 17.67% | - | - | -72.52% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.18% | 68.70% | 68.48% | 63.01% | 66.75% | 69.89% |
Operating Margin | 19.99% | 21.30% | 17.28% | 17.97% | 17.61% | 22.16% |
Pretax Margin | 24.91% | 27.55% | 30.54% | 25.92% | 25.01% | 28.46% |
Profit Margin | 21.46% | 24.02% | 28.09% | 24.25% | 24.67% | 24.61% |
FCF Margin | 25.49% | 28.93% | 20.41% | 18.45% | -13.27% | 1.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.214 | 0.214 | 0.179 | 0.143 | 0.128 | 0.128 |
Dividend Per Share Growth | 68.00% | 19.99% | 24.98% | 11.99% | 0% | 0% |
Dividend Yield | 2.96% | 2.94% | 3.42% | 2.10% | 1.97% | 1.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.18 | 17.10 | 12.59 | 20.84 | 20.24 | 22.22 |
P/FCF Ratio | 15.16 | 14.20 | 17.33 | 27.39 | - | 404.58 |
PS Ratio | 3.86 | 4.11 | 3.54 | 5.05 | 4.99 | 5.47 |